The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
Plasmid-mediated quinolone resistance: an update
Abstract
In 1998, the first plasmid-mediated gene involved in quinolone resistance (currently named qnrA1) was reported. Extra qnr-like plasmid-mediated genes (qnrB, qnrS, qnrC, qnrD) and their chromosomal homologues have also been characterized. These genes code for a pentapeptide repeat protein that protects type II topoisomerases from quinolones. Since then, there have been reports of two other plasmid-mediated resistance mechanisms: the modification of quinolones with a piperazinyl substituent by the acetyltransferase, Aac(6')-Ib-cr; and active efflux by QepA and OqxAB, pumps related to major facilitator superfamily (MFS) transporters. These genes have a wide geographic distribution (mainly in Enterobacteriaceae). Because of the difficulties of phenotypic detection of this type of resistance, its real prevalence is only partially known. One important point is that although these mechanisms cause only low-level resistance, they favor and complement the selection of other resistance mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is thought that this reduction in the DNA gyrase-DNA interaction decreases the opportunities of the quinolone molecule to form and stabilize the gyrase-cleaved DNA-quinolone complex that is lethal for the cell (55).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [55]
Citations
Cites
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,804
DNA gyrase, topoisomerase IV, and the 4-quinolones
Drlica, K., & Zhao, X. (1997) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.61.3.377-392.1997 · Cited by 1,272
Quinolone resistance from a transferable plasmid
Martı́nez-Martı́nez, L., Pascual, Á., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,104
Self-citationFluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A. A., Strahilevitz, J., Jacoby, G. A., Macielag, M. J., Abbanat, D., Park, C. H., Bush, K., & Hooper, D. C. (2005) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,011
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A. A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 965
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 926
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and Molecular Biology Reviews · doi:10.1128/.61.3.377-392.1997 · Cited by 896
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., et al. (1962) · Journal of Medicinal Chemistry · doi:10.1021/jm01240a021 · Cited by 770
Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme
Park, C. H., Robicsek, A. A., Jacoby, G. A., Sahm, D. F., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-06 · Cited by 755
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J. D. D., Peixe, L. M. S. V., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1402.070350 · Cited by 702
Cattoir, V., Poirel, L., Rotimi, V. O., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm204 · Cited by 677
Antibiotic Resistance Among Gram-Negative Bacilli in US Intensive Care Units
Neuhauser, M. M., Weinstein, R. A., Rydman, R. J., Danziger, L. H., Karam, G. H., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 672
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 578
qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States
Robicsek, A. A., Strahilevitz, J., Sahm, D. F., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01647-05 · Cited by 570
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 568
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
McConnell, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70621-1 · Cited by 543
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R. B., BRUNTON, J. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 539
Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China
Wang, M., Tran, J. H., Jacoby, G. A., Zhang, Y., Wang, F., & Hooper, D. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2242-2248.2003 · Cited by 467
Yamane, K., Wachino, J., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00339-07 · Cited by 466
Tumbarello, M., Sanguinetti, M., Montuori, E. A., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D’Inzeo, T., Fadda, G., Cauda, R., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-06 · Cited by 459
Cavaco, L. M., Hasman, H., Xia, S., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-08 · Cited by 445
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae
Nordmann, P., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki245 · Cited by 428
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Vilà, J., & Bonomo, R. A. (2007) · Future Microbiology · doi:10.2217/17460913.2.1.9 · Cited by 420
Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA
Poirel, L., Rodríguez-Martínez, J. M., Mammeri, H., Liard, A., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3523-3525.2005 · Cited by 403
Self-citationqnrB , Another Plasmid-Mediated Gene for Quinolone Resistance
Jacoby, G. A., Walsh, K. E., Mills, D. M., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1178-1182.2006 · Cited by 400
Paterson, D. L., Mülazımoğlu, L., Casellas, J. M., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313719 · Cited by 386
Cohen, S., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 375
Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period
Kim, H. B., Park, C. H., Kim, C.-J., Kim, E.-C., Jacoby, G. A., & Hooper, D. C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01051-08 · Cited by 348
Françoise Van Bambeke, A., Michot, J.-M., Eldere, J. V., & Tulkens, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01131.x · Cited by 342
Application of fluoroquinolone pharmacodynamics
Wright, D. H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.669 · Cited by 342
Emergence and Dissemination of Quinolone-Resistant Escherichia coli in the Community
Garau, J., Xercavins, M., Rodríguez‐Carballeira, M., Gómez-Vera, J. R., Coll, I., Vidal, D., Llovet, T., & Bremón, A. R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2736 · Cited by 337
Wang, M., Guo, Q., Xu, X., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01400-08 · Cited by 324
Quinolone generations: natural history or natural selection?
Ball, P. D. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020889 · Cited by 303
A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., & Blanchard, J. S. (2005) · Science · doi:10.1126/science.1110699 · Cited by 299
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in Shigella flexneri 2b
Hata, M., Suzuki, M., Matsumoto, M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.801-803.2005 · Cited by 288
Wang, H., Dzink-Fox, J., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283
Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella
García-Fernández, A., Fortini, D., Veldman, K. T., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn470 · Cited by 277
Périchon, B., Courvalin, P. M., & Galimand, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-07 · Cited by 271
oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
Kim, H. B., Wang, M., Park, C. H., Kim, E.-C., Jacoby, G. A., & Hooper, D. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-08 · Cited by 270
Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe
Mammeri, H., Loo, M. V. D., Poirel, L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.71-76.2005 · Cited by 262
Hansen, L. H., Jensen, L. B., Sørensen, H. I., & Sørensen, S. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm167 · Cited by 257
Routes of quinolone permeation in Escherichia coli
Chapman, J., & Georgopapadakou, N. H. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.438 · Cited by 254
Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from Japan
Yamane, K., Wachino, J., Suzuki, S., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01137-07 · Cited by 253
Interscience Conference on Antimicrobial Agents and Chemotherapy
(1961) · Folia Microbiologica · doi:10.1007/bf02864650 · Cited by 253
Wang, M., Sahm, D. F., Jacoby, G. A., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1295-1299.2004 · Cited by 244
Plasmid‐Mediated Quinolone Resistance in Non‐Typhi Serotypes of Salmonella enterica
Gay, K., Robicsek, A. A., Strahilevitz, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505397 · Cited by 243
Cattoir, V., Poirel, L., Aubert, C., Soussy, C., & Nordmann, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1402.070677 · Cited by 233
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 233
Lautenbach, E., Strom, B. L., Bilker, W. B., Patel, J. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/322667 · Cited by 230
Plasmid-Encoded Multidrug Efflux Pump Conferring Resistance to Olaquindox in Escherichia coli
Hansen, L. H., Johannesen, E., Burmølle, M., Sørensen, A. H., & Sørensen, S. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3332-3337.2004 · Cited by 214
DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
Zhao, X., Xu, C., Domagala, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13991 · Cited by 213
Oethinger, M. D., Kern, W. V., Jellen-Ritter, A., McMurry, L. M., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.10-13.2000 · Cited by 213
Prevalence of Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Chow, N. A., & Waites, K. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.559-562.2003 · Cited by 210
Jacoby, G. A., Cattoir, V., Hooper, D. C., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00147-08 · Cited by 202
Ma, J., Zeng, Z., Chen, Z., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00886-08 · Cited by 200
Ahmed, A. M., Motoi, Y., Sato, M., et al. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01054-07 · Cited by 200
Quinolone Antimicrobial Agents
Neu, H. C. (1992) · Annual Review of Medicine · doi:10.1146/annurev.med.43.1.465 · Cited by 197
Jiang, Y., Zhou, Z., Qian, Y., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn063 · Cited by 188
Vetting, M. W., Hegde, S. S., Fajardo, J. E., Fiser, A., Roderick, S. L., Takiff, H. E., & Blanchard, J. S. (2005) · Biochemistry · doi:10.1021/bi052130w · Cited by 186
The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell.
Garrido, M. C., Herrero, M., Kolter, R., & Moreno, F. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03018.x · Cited by 186
Shalit, I., Berger, S. A., Gorea, A., et al. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.593 · Cited by 168
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3050-3052.2005 · Cited by 167
Cagnacci, S., Gualco, L., Debbia, E. A., Schito, G. C., & Marchese, A. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
13th European Congress of Clinical Microbiology and Infectious Diseases
Yuen, L., Yuen, J., Boost, M., Benzie, I., & Wachtel-Galor, S. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.9.s1.83.x · Cited by 165
Wu, J.-J., Ko, W., Tsai, S.-H., & Yan, J.-J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01195-06 · Cited by 164
March, A., Aschbacher, R., Dhanji, H., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03024.x · Cited by 164
Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates
Morgan‐Linnell, S. K., Boyd, L. B., Steffen, D. L., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00665-08 · Cited by 162
Paton, J. H., & Reeves, D. S. (1988) · Drugs · doi:10.2165/00003495-198836020-00004 · Cited by 161
Bacterial Topoisomerases, Anti‐Topoisomerases, and Anti‐Topoisomerase Resistance
Hooper, D. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514923 · Cited by 161
Plasmid-Mediated Quinolone Resistance in Gram-Negative Bacterial Species: An Update
Cattoir, V., & Nordmann, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581879 · Cited by 145
Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants
Poirel, L., Liard, A., Rodríguez-Martínez, J. M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki371 · Cited by 145
Self-citationPitout, J. D. D., Gregson, D. B., Campbell, L., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-09 · Cited by 145
Verner–Jeffreys, D. W., Welch, T. J., Schwarz, T. I., Pond, M. J., Woodward, M. J., Haig, S., Rimmer, G. S. E., Roberts, E., Morrison, V., & Baker‐Austin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008388 · Cited by 143
Ysern, P., Clerch, B., Castańo, M., et al. (1990) · Mutagenesis · doi:10.1093/mutage/5.1.63 · Cited by 143
Karisik, E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl309 · Cited by 139
Plasmid-Mediated Quinolone Resistance Pump QepA2 in an Escherichia coli Isolate from France
Cattoir, V., Poirel, L., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00638-08 · Cited by 134
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro
Heisig, P., & Tschorny, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1284 · Cited by 134
Heddle, J. G., Blance, S. J., Zamble, D. B., Hollfelder, F., Miller, D. A., Wentzell, L. M., Walsh, C. T., & Maxwell, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4562 · Cited by 123
Poirel, L., Leviandier, C., & Nordmann, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00597-06 · Cited by 120
Interaction of plasmid and host quinolone resistance
Martı́nez-Martı́nez, L. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg157 · Cited by 119
Self-citationSánchez, M. B., Hernández, A., Rodríguez-Martínez, J. M., et al. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-148 · Cited by 116
Self-citationMontero, C. I., Mateu, G., Rodríguez, R., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3387-3392.2001 · Cited by 115
Yang, H. B., Chen, H., Yang, Q., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-08 · Cited by 114
Yue, L., Jiang, H., Liao, X., Liu, J., Li, S., Chen, X.-Y., Chen, C., Lü, D.-H., & Liu, Y. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.05.009 · Cited by 113
NewqnrGene Cassettes Associated with Superintegron Repeats inVibrio choleraeO1
da Fonseca, E. L., Freitas, F. D. S., Vieira, V. V., et al. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.080132 · Cited by 113
Plasmid-mediated quinolone resistance
Martı́nez-Martı́nez, L., Cano, M. E., Rodríguez-Martínez, J. M., et al. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.685 · Cited by 113
Self-citationLiu, J., Deng, Y., Zeng, Z., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-07 · Cited by 110
Lavilla, S., González‐López, J. J., Sabaté, M., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm448 · Cited by 110
Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered from a Swiss lake
Picão, R. C., Poirel, L., Demarta, A., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn341 · Cited by 110
Hopkins, K. L., Wootton, L., Day, M. R., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm081 · Cited by 109
Vibrio splendidus as the Source of Plasmid-Mediated QnrS-Like Quinolone Resistance Determinants
Cattoir, V., Poirel, L., Mazel, D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00070-07 · Cited by 109
Cheung, T. K. M., Chu, Y. W., Chu, M. Y., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki250 · Cited by 108
Pomba, C., da Fonseca, J. D., Baptista, B., Correia, J. D., & Martı́nez-Martı́nez, L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00896-08 · Cited by 107
Self-citationMinarini, L. A. D. R., Poirel, L., Cattoir, V., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn237 · Cited by 107
CORKILL, J. E., Anson, J. J., & Hart, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki388 · Cited by 106
Endimiani, A., Carias, L. L., Hujer, A. M., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00158-08 · Cited by 99
Wang, A., Yang, Y., Lu, Q., et al. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-68 · Cited by 98
Hernández-Allés, S., Benedi, V. J., Martı́nez-Martı́nez, L., Pascual, Á., Aguilar, A., Tomás, J. M., & Albertí, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.937 · Cited by 98
Self-citationOteo, J., Cuevas, Ó., Lopez-Rodriguez, I., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp211 · Cited by 98
Role of a qnr -Like Gene in the Intrinsic Resistance of Enterococcus faecalis to Fluoroquinolones
Arsene, S., & Leclercq, R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00274-07 · Cited by 96
Temporal Appearance of Plasmid-Mediated Quinolone Resistance Genes
Jacoby, G. A., Gacharna, N., Black, T. A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01447-08 · Cited by 96
Bönemann, G., Stiens, M., Pühler, A., & Schlüter, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00378-06 · Cited by 95
Cavaco, L. M., Frimodt‐Møller, N., Hasman, H., et al. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0821 · Cited by 89
Quiroga, M. P., Andres, P. O., Petroni, A., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00726-07 · Cited by 89
Castanheira, M., Mendes, R. E., Rhomberg, P. R., & Jones, R. N. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0827 · Cited by 88
Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria
Iabadene, H., Messai, Y., Ammari, H., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn145 · Cited by 87
Poirel, L., Pitout, J. D. D., Calvo, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1525-1527.2006 · Cited by 86
Vien, L. T. M., Baker, S. G., Thảo, L. T. P., et al. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.010033-0 · Cited by 85
Pitout, J. D. D., Wei, Y., Church, D. L., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn068 · Cited by 85
Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China
Cui, S., Li, J., Sun, Z., Hu, C., Jin, S. Y., Li, F., Guo, Y., Ran, L., & Ma, Y. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn452 · Cited by 84
Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates Part 2: Human Trials
Schentag, J. J., Meagher, A. K., & Forrest, A. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c419 · Cited by 84
SmQnr Contributes to Intrinsic Resistance to Quinolones in Stenotrophomonas maltophilia
Sánchez, M. B., & Martínez, J. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00496-09 · Cited by 83
Hansen, L. H., S⊘rensen, S. J., Jørgensen, H. S., et al. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.378 · Cited by 81
Allou, N., Cambau, E., Massias, L., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01664-08 · Cited by 80
Rodríguez-Martínez, J. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg388 · Cited by 79
Self-citationAssociation of Plasmid-Mediated Quinolone Resistance with Extended-Spectrum β-Lactamase VEB-1
Poirel, L., Loo, M. V. D., Mammeri, H., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3091-3094.2005 · Cited by 78
Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China
Pu, X., Pan, J., Wang, H.-Q., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp087 · Cited by 76
Rodríguez-Martínez, J. M., Velasco, C., Garcı́a, I., Cano, M. E., Martı́nez-Martı́nez, L., & Pascual, Á. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-06 · Cited by 75
Self-citationRodríguez-Martínez, J. M., Velasco, C., Pascual, Á., et al. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01389.x · Cited by 73
Self-citationGunell, M., Webber, M. A., Kotilainen, P., Lilly, A. J., Caddick, J. M., Jalava, J., Huovinen, P., Siitonen, A., Hakanen, A., & Piddock, L. J. V. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00121-09 · Cited by 71
Fabre, L., Delauné, A., Espié, E., Nygård, K. M., de la Gándara, M. P., Polomack, L., Guesnier, F., Galimand, M., Lassen, J. F., & Weill, F. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00451-08 · Cited by 71
Pitout, J. D. D., Campbell, L., Church, D. L., Gregson, D. B., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00061-09 · Cited by 70
Touati, A., Brasme, L., Benallaoua, S., et al. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.002 · Cited by 69
Crémet, L., Caroff, N., Dauvergne, S., et al. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.04.003 · Cited by 69
Qnr-like pentapeptide repeat proteins in Gram-positive bacteria
Rodríguez-Martínez, J. M., Velasco, C., Briales, A., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn115 · Cited by 68
Self-citationMartı́nez-Martı́nez, L., Pascual, Á., Conejo, M. C., Garcı́a, I., Joyanes, P., Doménech‐Sánchez, A., & Benedi, V. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3926-3932.2002 · Cited by 68
Self-citationSoge, O. O., Adeniyi, B. A., & Roberts, M. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl370 · Cited by 68
Tamang, M. D., Seol, S. Y., Oh, J.-Y., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01633-07 · Cited by 67
Cesaro, A., Bettoni, R. R. D., Lascols, C., Mérens, A., Soussy, C., & Cambau, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn077 · Cited by 67
GyrI: a counter‐defensive strategy against proteinaceous inhibitors of DNA gyrase
Chatterji, M., & Nagaraja, V. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf038 · Cited by 66
Rice, L. B., Carias, L. L., Hutton, R. A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00493-08 · Cited by 66
Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia
Dahmen, S., Poirel, L., Mansour, W., Bouallègue, O., & Nordmann, P. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03010.x · Cited by 65
Sm qnr , a New Chromosome-Carried Quinolone Resistance Gene in Stenotrophomonas maltophilia
Shimizu, K., Kikuchi, K., Sasaki, T., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00026-08 · Cited by 65
Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates
Schentag, J. J., Meagher, A. K., & Forrest, A. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c199 · Cited by 65
Jones, G., Warren, R. E., Skidmore, S., Davies, V. A., Gibreel, T. M., & Upton, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn406 · Cited by 65
IS Ecp1 -Mediated Transposition of qnrB -Like Gene in Escherichia coli
Cattoir, V., Nordmann, P., Silva-Sánchez, J., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-08 · Cited by 65
SOS Regulation of qnrB Expression
Wang, M., Jacoby, G. A., Mills, D. M., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00132-08 · Cited by 64
Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005
Cambau, E., Lascols, C., Sougakoff, W., et al. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01529.x · Cited by 63
Libisch, B., Poirel, L., Lepšanović, Z., et al. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00483.x · Cited by 63
Nazic, H., Poirel, L., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2146-2147.2005 · Cited by 62
Özgümüş, O. B., Sandallı, C., Sevim, A., et al. (2009) · The Journal of Microbiology · doi:10.1007/s12275-008-0206-z · Cited by 58
Cano, M. E., Rodríguez-Martínez, J. M., Agüero, J., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02229-08 · Cited by 56
Self-citationMendes, R. E., Bell, J. M., Turnidge, J. D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01185-07 · Cited by 55
Poirel, L., Cattoir, V., Soares, A., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01082-06 · Cited by 55
Ahmed, A. M., Younis, E., Ishida, Y., et al. (2009) · Acta Tropica · doi:10.1016/j.actatropica.2009.04.004 · Cited by 54
Aschbacher, R., Doumith, M., Livermore, D. M., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm508 · Cited by 54
Saga, T., Kaku, M., Onodera, Y., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2144-2145.2005 · Cited by 51
Shin, S., Kwon, K. C., Park, J. W., et al. (2009) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2009.29.6.541 · Cited by 51
Jung, C. M., Heinze, T. M., Strakosha, R., et al. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.04026.x · Cited by 50
qnrA in CTX-M-Producing Escherichia coli Isolates from France
Lavigne, J., Marchandin, H., Delmas, J., Bouziges, N., Lecaillon, E., Cavalié, L., Jean‐Pierre, H., Bonnet, R., & Sotto, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00904-06 · Cited by 50
Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents
Chatterji, M., Sengupta, S., & Nagaraja, V. (2003) · Archives of Microbiology · doi:10.1007/s00203-003-0598-4 · Cited by 49
Öktem, İ. M. A., Gülay, Z., Biçmen, M., et al. (2008) · PubMed · Cited by 49
Berçot, B., Poirel, L., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00882-08 · Cited by 48
High Prevalence of qnr Genes in Commensal Enterobacteria from Healthy Children in Peru and Bolivia
Pallecchi, L., Riccobono, E., Mantella, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01722-08 · Cited by 48
Expanded-spectrum β-Lactamase and Plasmid-mediated Quinolone Resistance
Poirel, L., Villa, L., Bertini, A., et al. (2007) · Emerging infectious diseases · doi:10.3201/eid1305.061293 · Cited by 47
Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claims
Smith, H. J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf047 · Cited by 47
Baudry, P. J., Nichol, K. A., DeCorby, M. R., et al. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.12.001 · Cited by 47
Chmelnitsky, I., Navon‐Venezia, S., Strahilevitz, J., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01341-07 · Cited by 46
Wu, J.-J., Ko, W., Wu, H.-Y., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn111 · Cited by 46
Cerquetti, M., García-Fernández, A., Giufrè, M., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00239-09 · Cited by 45
Molecular characterization of antimicrobial resistance inSalmonellaisolated from animals in Japan
Ahmed, A. M., Ishida, Y., & Shimamoto, T. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.04009.x · Cited by 45
Avguštin, J. A., Keber, R., Žerjavic, K., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01480-06 · Cited by 45
Fihman, V., Lartigue, M.-F., Jacquier, H., et al. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.03.010 · Cited by 45
Ahmed, A. M., Younis, E., Osman, S. A., et al. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.11.021 · Cited by 45
Kehrenberg, C., Hopkins, K. L., Threlfall, E. J., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm283 · Cited by 44
Rodríguez-Martínez, J. M., Pichardo, C., Garcı́a, I., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02020.x · Cited by 43
Self-citationShin, J. H., Jung, H. J., Lee, J. Y., et al. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0834 · Cited by 42
Hakanen, A., Lindgren, M., Huovinen, P., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5775-5778.2005 · Cited by 42
Sjölund-Karlsson, M., Folster, J. P., Pecic, G., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-08 · Cited by 42
Plasmid-Mediated QnrS2 Determinant from a Clinical Aeromonas veronii Isolate
Sánchez‐Céspedes, J., Blasco, M. D., Martí, S., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00287-08 · Cited by 42
Coexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae
Hu, F., Xu, X., Zhu, D., & Wang, M. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00757.x · Cited by 41
Watanabe, M., Kotera, Y., Yosue, K., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.173 · Cited by 41
Rodríguez-Martínez, J. M., Briales, A., Velasco, C., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp111 · Cited by 41
Self-citationKim, E. S., Jeong, J., Jun, J., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01534-08 · Cited by 41
Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel
Chmelnitsky, I., Hermesh, O., Navon‐Venezia, S., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp272 · Cited by 41
Lascols, C., Podglajen, I., Verdet, C., Gautier, V., Gutmann, L., Soussy, C., Collatz, E., & Cambau, E. (2008) · Journal of Bacteriology · doi:10.1128/jb.00243-08 · Cited by 41
Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa
Masecar, B. L., Celesk, R. A., & Robillard, N. J. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.281 · Cited by 40
Ode, T., Saito, R., Kumita, W., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.05.007 · Cited by 40
Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives
Michel-Briand, Y., Uccelli, V., Laporte, J.-M., et al. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.6.667 · Cited by 40
Emergence of Qnr determinants in human Salmonella isolates in Taiwan
Wu, J.-J., Ko, W., Chiou, C., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn426 · Cited by 39
First report of qnr genes in Salmonella in The Netherlands
Veldman, K. T., van Pelt, W., & Mevius, D. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm495 · Cited by 39
Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features
Blondeau, J. M., & Hansen, G. T. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.2.317 · Cited by 39
Kanj, S. S., CORKILL, J. E., Kanafani, Z. A., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01964.x · Cited by 38
Huang, S., Dai, L., Xia, L., et al. (2009) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2009.0348 · Cited by 38
Clinical isolate of Citrobacter freundii highly resistant to new quinolones
Aoyama, H., Fujimaki, K., Sato, K., et al. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.922 · Cited by 38
Fluoroquinolone resistance and plasmid addiction systems: self-imposed selection pressure?
Ellington, M. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl110 · Cited by 38
Park, Y.-J., Yu, J. K., Kim, S.-I., et al. (2009) · PubMed · Cited by 36
Plasmid-Mediated Quinolone Resistance in Australia
Rodríguez-Martínez, J. M., Poirel, L., Pascual, Á., et al. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.99 · Cited by 35
Self-citationKim, S. Y., Park, Y.-J., Yu, J. K., et al. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.11.016 · Cited by 34
Dionisi, A. M., Lucarelli, C., Owczarek, S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-09 · Cited by 34
Novel Variant of the qnrB Gene, qnrB12 , in Citrobacter werkmanii
Kehrenberg, C., Friederichs, S., de Jong, A., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01042-07 · Cited by 34
Prevalence and Expression of the Plasmid-Mediated Quinolone Resistance Determinant qnrA1
Xu, X., Wu, S., Ye, X., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00616-07 · Cited by 34
The in vitro activity of BMS-284756, a new des-fluorinated quinolone
Weller, T. M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.177 · Cited by 34
Plasmid-mediated quinolone resistance determinant qnrS in Enterobacter cloacae
Poirel, L., Nguyen, T. V., Weintraub, A., Leviandier, C., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01531.x · Cited by 33
Hussein, A. I. A., Ahmed, A. M., Sato, M., et al. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2009.00168.x · Cited by 33
Hammad, A. M., Ishida, Y., & Shimamoto, T. (2009) · Journal of Food Protection · doi:10.4315/0362-028x-72.3.624 · Cited by 32
Gibson, J. S., Cobbold, R. N., Heisig, P., et al. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.11.031 · Cited by 32
Kim, E. S., Jeong, J., Choi, S., et al. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.07.006 · Cited by 32
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Mechanisms of antibiotic resistance
Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421
Metadata
- Authors
- Rodríguez-Martínez, J. M., Velasco, C., Pascual, Á., Cano, M. E., Martínez-Martínez, L., Martínez-Martínez, L., & Pascual, Á.
- Affiliations
- Universidad de Sevilla (ES)
- Marqués de Valdecilla University Hospital (ES)
- Corresponding author
- Rodríguez-Martínez, José Manuel
- Velasco, Carmen
- Cano, María Eliecer
- Venue
- Journal of Infection and Chemotherapy
- Publisher
- Elsevier BV
- Published
- 2011
- Volume
- 17
- Issue
- 2
- Pages
- 149-182
- ISSN
- 1341-321X (ISSN-L)
- OpenAlex
- W1964492646
- Cited by
- 306
- References
- 260
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 15 · 2023: 8 · 2022: 25 · 2021: 15 · 2020: 19 · 2019: 14 · 2018: 21 · 2017: 22 · 2016: 33 · 2015: 19 · 2014: 28 · 2013: 28 · 2012: 26
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Infection and Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- plasmid-mediated quinolone resistance, qnr genes, qnrA, qnrB, qnrS, qnrD, aac(6')-Ib-cr, qepA, oqxAB, major facilitator superfamily transporter, efflux pumps, Enterobacteriaceae, antibiotic resistance mechanisms, resistance prevalence
- MeSH terms
- Acetyltransferases, Anti-Bacterial Agents, Bacterial Proteins, Enterobacteriaceae, Enterobacteriaceae Infections, Humans, Microbial Sensitivity Tests, Plasmids, Quinolones, Prevalence, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review